In line with this - dual - vascular and hepatic/lipid phenotype, MIF-2 was found to be markedly upregulated in unstable carotid plaques and in plasma of CAD patients, where higher MIF-2 levels were measured in patients with ACS compared to CCS, correlating with clinical parameters. This evidence concerns the gene DDT and coronary artery disorder.